Lung Cancer Rx

Neoadjuvant Therapy for Early-Stage Lung Cancer: Where Do Things Stand, and What’s Next?

29 min · 1 de may de 2026
Portada del episodio Neoadjuvant Therapy for Early-Stage Lung Cancer: Where Do Things Stand, and What’s Next?

Descripción

Given recent advances, where do things stand for neoadjuvant therapy in patients with NSCLC? The panel discusses current considerations and what important questions may soon be answered. Patrick Forde MBBCh, PhD, a thoracic medical oncologist at Johns Hopkins University in Baltimore, Maryland, and professor of immuno-oncology at Trinity College Dublin discusses current multidisciplinary approaches to perioperative care in NSCLC with Eric K. Singhi, MD, a thoracic oncologist in Houston, and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Lung Cancer Rx!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

12 episodios